OGEN (Oragenics) Cyclically Adjusted PB Ratio: (As of Aug. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OGEN Oragenics Inc OGEN
30 GF Score
Price $0.55
! 1 Warning Sign
View Full Analysis

What is Oragenics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Oragenics  (AMEX:OGEN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Oragenics Cyclically Adjusted PB Ratio Related Terms


Oragenics Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Oragenics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oragenics Cyclically Adjusted PB Ratio Chart

Oragenics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.39 0.10 0.12 0.02 0.00

Oragenics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.00 0.00 0.00 0.00

OGEN vs CMND, SLXN, GRI: Cyclically Adjusted PB Ratio Comparison

For the Biotechnology subindustry, Oragenics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oragenics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oragenics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Oragenics's Cyclically Adjusted PB Ratio falls into.


OGEN
30GF Score
Oragenics Inc OGEN
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oragenics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Oragenics's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Oragenics's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.829/333.9520*333.9520
=0.829

Current CPI (Jun. 2026) = 333.9520.

Oragenics Quarterly Data

Book Value per Share CPI Adj_Book
201609 1,495.333 241.428 2,068.399
201612 988.667 241.432 1,367.538
201703 395.333 243.801 541.516
201706 7.667 244.955 10.453
201709 -77.667 246.819 -105.085
201712 2.000 246.524 2.709
201803 -595.000 249.554 -796.226
201806 -816.333 251.989 -1,081.857
201809 716.600 252.439 947.991
201812 923.875 251.233 1,228.063
201903 869.654 254.202 1,142.488
201906 688.846 256.143 898.098
201909 550.231 256.759 715.655
201912 412.269 256.974 535.766
202003 220.538 258.115 285.334
202006 52.032 257.797 67.403
202009 72.500 260.280 93.021
202012 189.608 260.474 243.095
202103 521.766 264.877 657.833
202106 462.708 271.696 568.732
202109 398.292 274.310 484.891
202112 366.600 278.802 439.117
202203 275.138 287.504 319.588
202206 217.385 296.311 245.000
202209 180.692 296.808 203.305
202212 170.388 296.797 191.718
202303 129.119 301.836 142.858
202306 84.537 305.109 92.529
202309 57.023 307.789 61.870
202312 15.291 306.746 16.647
202403 6.926 312.332 7.405
202406 -1.435 314.175 -1.525
202409 4.744 315.301 5.025
202412 -0.506 315.605 -0.535
202503 0.193 319.799 0.202
202506 -2.586 322.561 -2.677
202509 2.382 324.800 2.449
202512 1.938 324.054 1.997
202603 1.413 330.213 1.429
202606 0.829 333.952 0.829

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Oragenics Business Description

Address 9015 Town Center Parkway, Suite 143, Lakewood Ranch, FL, USA, 34202
Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.
30GF Score

Get the complete analysis for OGEN

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.55
Price